Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study

Chiara Zanetta; Maria A Rocca; Alessandro Meani; Vittorio Martinelli; Laura Ferrè; Lucia Moiola; Massimo Filippi

doi:10.1007/s00415-023-11772-5

Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing-remitting multiple sclerosis patients: a monocentric longitudinal observational study

J Neurol. 2023 Jul;270(7):3565-3566. doi: 10.1007/s00415-023-11772-5.

Authors

Chiara Zanetta^{1

2}, Maria A Rocca^{1

3

4}, Alessandro Meani³, Vittorio Martinelli¹, Laura Ferrè^{1

2}, Lucia Moiola¹, Massimo Filippi^{5

6

7

8

9}

Affiliations

¹ Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy.
² Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
³ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
⁴ Vita-Salute San Raffaele University, Milan, Italy.
⁵ Neurology Unit, IRCCS San Raffaele Scientific Institute, Via Olgettina, 60, 20132, Milan, Italy. filippi.massimo@hsr.it.
⁶ Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁷ Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.
⁸ Vita-Salute San Raffaele University, Milan, Italy. filippi.massimo@hsr.it.
⁹ Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy. filippi.massimo@hsr.it.

No abstract available

Publication types

Published Erratum